The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.




Bambino Gesu Children's Hospital - $49,803

Amount
$49,803.00
Date

August 2019

Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.

Telethon Kids Institute - $49,512

Amount
$49,512.00
Date

August 2019

Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Oncoceutics ONC201 - Phase II - $83,333

Amount
$83,333.00
Date

May 2019

Expansion of the ONC201 Compassionate Use.

Funding of Pediatric Brain Tumor Consortium Foundation - $25,000

Amount
$25,000.00
Date

January 2019

Sydney Children’s Hospital - $175,089

Amount
$175,089.00
Date

November 2018

Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital - $540,742

Amount
$540,742.00
Date

November 2018

Expansion of the International DIPG Registry.

Bambino Gesú Children's Hospital - $99,382

Amount
$99,382.00
Date

November 2018

Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000

Amount
$35,000.00
Date

November 2018

Credentialing an Improved DIPG Mouse Model.

Oncoceutics ONC201 - $83,333

Amount
$83,333.00
Date

October 2018

Expansion of the ONC201 Compassionate Use.

The Institute of Cancer Research - $100,000

Amount
$100,000.00
Date

October 2018

Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

The Institute of Cancer Research - $106,647

Amount
$106,647.00
Date

October 2018

A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.

Johns Hopkins Children's Center - $50,000

Amount
$50,000.00
Date

July 2018

Using Zebrafish to Accelerate DIPG Drug Development.

Funding of Pediatric Brain Tumor Consortium Foundation - $16,800

Amount
$16,800.00
Date

January 2018

The Campbell Family Institute for Cancer Research - $100,000

Amount
$100,000.00
Date

October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Institute of Cancer Research - $102,432

Amount
$102,432.00
Date

October 2017

Combinational strategies alongside ACVR1 inhibition in DIPG